Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dana A. Schaar"'
Autor:
Jacqueline W. Mays, Sandra A. Mitchell, Filip Pirsl, Lindsay M. Morton, Claire L. Ruben, Galen O. Joe, Leora E. Comis, Jeannette Nashed, Seth M. Steinberg, Steven Z. Pavletic, Pashna N. Munshi, Alen Ostojić, Noa G. Holtzman, Dana A. Schaar, Edward W. Cowen
Publikováno v:
Transplant Cell Ther
Subsequent cancer (SC) is a significant cause of morbidity and mortality in long-term survivors after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic graft-versus-host disease (cGVHD) and treatment-related immunosuppression ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7311e55e0436447aec5fb19af942d6d8
https://pubmed.ncbi.nlm.nih.gov/34380090
https://pubmed.ncbi.nlm.nih.gov/34380090
Autor:
Dana A. Schaar, Lauren M. Curtis, Ann M. Berger, Annie Im, Manuel B. Datiles, Jeannette Nashed, Galen O. Joe, Shaneil Flucker, Edward W. Cowen, Jacqueline W. Mays, Claire L. Ruben, Michael Emanuel, Pashna N. Munshi, Steven Z. Pavletic, Filip Pirsl, Laura Parsons-Wandell, Seth M. Steinberg
Publikováno v:
Blood. 134:4558-4558
Among patients who survive over two years post-allo-HSCT, cGVHD and subsequent cancers represent a significant source of morbidity and mortality. Long-term treatment with immunosuppressive agents and cGVHD-related immune dysregulation may promote the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3662a9b1950c9e90754a16b921d1d893
https://doi.org/10.1182/blood-2019-124020
https://doi.org/10.1182/blood-2019-124020